Skip to main content
SpringerLink
Log in

High-dose fluconazole should reduce mortality at acceptable cost

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Chen H, Suda KJ, Turpin RS, PAI MP, Bearden DT, Garey KW.High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysis. Current Medical Research and Opinion 23: 1057-1065, No. 5, May 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

High-dose fluconazole should reduce mortality at acceptable cost. Pharmacoecon. Outcomes News 532, 5 (2007). https://doi.org/10.2165/00151234-200705320-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705320-00006

Keywords

Search

Navigation